Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06254794 · ClinicalTrials.gov registry record · NA
Effect of BFR Rehab After Achilles Tendon Rupture
A NA study of Achilles Tendon Rupture, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT06254794: Recruiting NA study of Achilles Tendon Rupture, sponsored by The Methodist Hospital Research Institute.
NCT06254794 is a NA study of Achilles Tendon Rupture that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06254794, a NA study of Achilles Tendon Rupture, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.
Primary Outcome
Lean mass for lower extremity measured in kilograms (kg) using Dual-Energy-Xray-Absorptiometry (DEXA).
Conditions Studied
Interventions
- OTHER Physical therapy
- DEVICE Blood flow restriction with Delfi Personalized Tourniquet System (PTS)
Study Locations (1)
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT06254794 shows while recruiting
NCT06254794 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Achilles Tendon Rupture appearing as the primary indexed condition, and to 2 interventions - of which Physical therapy is the first listed.
NCT06254794 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06254794 about?
NCT06254794 is a clinical study titled "Effect of BFR Rehab After Achilles Tendon Rupture". The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.
What is the current status of trial NCT06254794?
This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2018-11-13. Estimated completion is 2028-12.
What conditions does trial NCT06254794 study?
This clinical trial studies the following conditions: Achilles Tendon Rupture.
What interventions are being tested in trial NCT06254794?
The interventions under investigation include: Physical therapy (OTHER), Blood flow restriction with Delfi Personalized Tourniquet System (PTS) (DEVICE).
Who is sponsoring clinical trial NCT06254794?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06254794 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Achilles Tendon Rupture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06254794's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI